Molecular portrait of chronic joint diseases: Defining endotypes toward personalized medicine - 30/04/24
Highlights |
• | Joint diseases constitute a major societal, economic, and individual burden. |
• | Clinical phenotyping has ameliorated disease classification. |
• | A better definition of disease endotypes will drive precision medicine. |
Abstract |
Joint diseases affect hundreds of millions of people worldwide, and their prevalence is constantly increasing. To date, despite recent advances in the development of therapeutic options for most rheumatic conditions, a significant proportion of patients still lack efficient disease management, considerably impacting their quality of life. Through the spectrum of rheumatoid arthritis (RA), psoriatic arthritis (PsA), and osteoarthritis (OA) as quintessential and common rheumatic diseases, this review first provides an overview of their epidemiological and clinical features before exploring how the better definition of clinical phenotypes has helped their clinical management. It then discusses the recent progress in understanding the diversity of endotypes underlying disease phenotypes. Finally, this review highlights the current challenges of implementing molecular endotypes towards the personalized management of RA, PsA and OA patients in the future.
Le texte complet de cet article est disponible en PDF.Keywords : Joint, Inflammation, Personalized medicine, Phenotypes, Biomarkers, Endotypes
Plan
Vol 91 - N° 3
Article 105692- mai 2024 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?